Vimian Group AB (publ) (OTCMKTS:VIMGF – Get Rating)’s share price dropped 15.1% during trading on Friday . The stock traded as low as C$2.65 and last traded at C$2.65. Approximately 100 shares changed hands during trading, a decline of 78% from the average daily volume of 450 shares. The stock had previously closed at C$3.12.
Analyst Upgrades and Downgrades
VIMGF has been the topic of several analyst reports. Jefferies Financial Group initiated coverage on Vimian Group AB (publ) in a report on Tuesday, November 29th. They set a “buy” rating on the stock. Barclays lowered Vimian Group AB (publ) from an “overweight” rating to an “equal weight” rating in a report on Tuesday, November 22nd.
Vimian Group AB (publ) Stock Down 15.1 %
The stock’s fifty day moving average is C$2.98.
Vimian Group AB (publ) Company Profile
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.
Recommended Stories
- Get a free copy of the StockNews.com research report on Vimian Group AB (publ) (VIMGF)
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
- Europe Raises Interest Rates, Should the Fed Follow?
Receive News & Ratings for Vimian Group AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vimian Group AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
